Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Jan 14 | 2020JPM 2020 Day 2: LLY, NVO, LVGO, SNY, PODD, ABT, and BDPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Jan 13 | 2020JPM 2020 Day 1: DXCM, LVGO, Novo, Bigfoot Biomedical, Companion Medical, MDTPurchase Blast
$599
Posted in: Glucose Monitoring Jan 09 | 2020Livongo Partners with Higi; Dario Hires New President and Head of NAPurchase Blast
$599
Posted in: Glucagon Jan 07 | 2020Xeris RTU Glucagon Ph2 Results for Exercise-Induced HypoglycemiaPurchase Blast
$599
Posted in: Bolus Insulin, SGLT2i Jan 06 | 2020Farxiga DAPA-HF receives priority review; Fiasp pediatric approval in US; MannKind launching in BrazilPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, GLP-1RA + Basal, Glucagon, Glucose Monitoring, Insulin Delivery, Other, SGLT2i Jan 03 | 2020Thoughts on ADA 2020 Standards of CarePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Jan 02 | 2020Novo Launches Insulin Savings ProgramPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Other Dec 19 | 2019Novo/UVA Partnership; Roche Decreases Eversense CGM Commitment; Lilly Insulin Pricing Open LetterPurchase Blast
$599
Posted in: Basal Insulin Dec 18 | 2019Rezolute Ultra-long-acting Basal Insulin (AB101) Ph1 Topline ResultsPurchase Blast
$599
Posted in: Insulin Delivery, SGLT2i Dec 17 | 2019Medtronic Acquires Klue; New Tandem SGLT2i+Closed-loop TrialPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Insulin Delivery, SGLT2i Dec 17 | 2019Tirzepatide CVOT vs. Trulicity; Lilly 2020 Guidance SummaryPurchase Blast
$599
Posted in: SGLT2i Dec 16 | 2019AZ Updates Farxiga Heart Failure Promotion on WebsitesPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Dec 16 | 2019Lilly/Dexcom Updated Partnership for CGMPurchase Blast
$599
Posted in: Insulin Delivery Dec 13 | 2019Tandem Control IQ Approved as first "iAlgorithm" DevicePurchase Blast
$599
Posted in: SGLT2i Dec 13 | 2019Jardiance EMPERIAL Studies Fail to Show HF Symptom ImprovementPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Dec 12 | 2019Teplizumab Regulatory Update; Sanofi Partners with Biocorp; Livongo Preferred on ESI; Omnipod Horizon Pivotal Trial Initiated; Glooko Partners with Mellitus HealthPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal Dec 12 | 2019Would AZ, Teva, or Mylan/Upjohn Buy Sanofi's DCV Business?Purchase Blast
$599
Posted in: Basal Insulin, Glucagon, Glucose Monitoring, Insulin Delivery Dec 11 | 2019Xeris Positive Ph2 Data in PBH; Oramed Partnership with Tianhui; Glooko Privacy Shield CertificationPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
